Anti-Infective Drugs Global Market Opportunities And Strategies To 2022 Including: By Product Type: Antibiotics, Antivirals, Antifungals, Others Covering: Gilead Sciences, GlaxoSmithKline, Merck & Co, Teva Pharmaceutical Industries Ltd., Johnson & Johnson
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Anti-Infective Drugs Global Market Opportunities And Strategies To 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global anti-infective drugs market.
Reasons to Purchase
Outperform competitors using accurate up to date demand-side dynamics information.
Identify growth segments for investment.
Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
Create regional and country strategies on the basis of local data and analysis.
Stay abreast of the latest customer and market research findings
Benchmark performance against key competitors.
Develop strategies based on likely future developments.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Gain a global perspective on the development of the market.
Description:
Where is the largest and fastest growing market for the anti-infective drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global anti-infective drugs market report to 2022 report answers all these questions and many more.
The report covers the following chapters
Executive Summary The executive summary section of the report gives a brief overview and summary of the report
Report Structure This section gives the structure of the report and the information covered in the various sections.
Market Characteristics The market characteristics section of the report defines and explains the anti-infective drugs market. This chapter identifies the different products covered in the report and basic definitions.
Supply Chain The supply chain section of the report defines and explains the key players in the anti-infective drugs industry supply chain.
Trends And Strategies This chapter describes the major trends shaping the global anti-infective drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
PESTEL Analysis This chapter describes the market opportunity assessment through PESTEL analysis.
Global Market Size And Growth This section contains the global historic (2014-2018) and forecast (2018-2022) market value, and drivers and restraints that support and control the growth of the market in the historic and forecast period.
Regional Analysis This section contains the historic (2014-2018) and forecast (2018-2022) market value and growth, and market share comparison by region.
Market Segmentation This section contains the market values (2014-2022) and analysis for different market segments.
Global Macro Comparison The global anti-infective drugs market comparison with macro-economic factors gives the anti-infective drugs market size, percentage of GDP, and average anti-infective drugs market expenditure.
Regional Market Size and Growth This section contains the regions market size (2018), historic (2014-2018) and forecast (2018-2022) market value, and growth and market share comparison of major countries within the region. This section also gives information on industry metrics which affect or influence the anti-infective drugs market. Industry metrics covered in this section include per capita average anti-infective drugs market expenditure. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa) and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
Competitive Landscape This section covers details on the competitive landscape of the global anti-infective drugs market, estimated market shares and company profiles of the leading players.
Key Mergers And Acquisitions This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Background This section describes the pharmaceutical drugs market of which the anti-infective drugs market is a segment. This chapter includes the global pharmaceutical drugs market 2014-18 and 2018-22 values, and regional analysis for the pharmaceutical drugs market.
Conclusions & Recommendations This section includes conclusions and recommendations are based on findings of the research. This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Appendix This section includes details on the market data sources, abbreviations and currencies codes used in this report.
Markets Covered:
By Product Type: Antibiotics, Antivirals, Antifungals and Others
Antibiotics is further segmented into ?-Lactams, Quinolones, Macrolides, Aminoglycosides and Others
Antivirals is further segmented into Hepatitis Therapeutics, Herpes Therapeutics, HIV AIDS Therapeutics and Influenza Therapeutics
Antifungals is further segmented into Azoles and Others
Companies Mentioned: Gilead Sciences, GlaxoSmithKline, Merck & Co, Teva Pharmaceutical Industries Ltd., Johnson & Johnson
Countries: China, Japan, India, Australia, Indonesia, Malaysia, New Zealand, Philippines, Singapore, South Korea, Thailand, Vietnam, Canada, Mexico, USA, Argentina, Brazil, Chile, Colombia, Peru, Venezuela,UK, Belgium, Denmark, Finland, France, Ireland, Italy, Netherlands, Norway, Portugal, Sweden , Switzerland, Germany, France, Spain, Czech Republic, Poland, Romania, Russia, Saudi Arabia, Israel, Turkey, UAE, Egypt, Nigeria, South Africa.
Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
Outperform competitors using accurate up to date demand-side dynamics information.
Identify growth segments for investment.
Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
Create regional and country strategies on the basis of local data and analysis.
Stay abreast of the latest customer and market research findings
Benchmark performance against key competitors.
Develop strategies based on likely future developments.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Gain a global perspective on the development of the market.
Description:
Where is the largest and fastest growing market for the anti-infective drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global anti-infective drugs market report to 2022 report answers all these questions and many more.
The report covers the following chapters
Executive Summary The executive summary section of the report gives a brief overview and summary of the report
Report Structure This section gives the structure of the report and the information covered in the various sections.
Market Characteristics The market characteristics section of the report defines and explains the anti-infective drugs market. This chapter identifies the different products covered in the report and basic definitions.
Supply Chain The supply chain section of the report defines and explains the key players in the anti-infective drugs industry supply chain.
Trends And Strategies This chapter describes the major trends shaping the global anti-infective drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
PESTEL Analysis This chapter describes the market opportunity assessment through PESTEL analysis.
Global Market Size And Growth This section contains the global historic (2014-2018) and forecast (2018-2022) market value, and drivers and restraints that support and control the growth of the market in the historic and forecast period.
Regional Analysis This section contains the historic (2014-2018) and forecast (2018-2022) market value and growth, and market share comparison by region.
Market Segmentation This section contains the market values (2014-2022) and analysis for different market segments.
Global Macro Comparison The global anti-infective drugs market comparison with macro-economic factors gives the anti-infective drugs market size, percentage of GDP, and average anti-infective drugs market expenditure.
Regional Market Size and Growth This section contains the regions market size (2018), historic (2014-2018) and forecast (2018-2022) market value, and growth and market share comparison of major countries within the region. This section also gives information on industry metrics which affect or influence the anti-infective drugs market. Industry metrics covered in this section include per capita average anti-infective drugs market expenditure. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa) and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
Competitive Landscape This section covers details on the competitive landscape of the global anti-infective drugs market, estimated market shares and company profiles of the leading players.
Key Mergers And Acquisitions This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Background This section describes the pharmaceutical drugs market of which the anti-infective drugs market is a segment. This chapter includes the global pharmaceutical drugs market 2014-18 and 2018-22 values, and regional analysis for the pharmaceutical drugs market.
Conclusions & Recommendations This section includes conclusions and recommendations are based on findings of the research. This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Appendix This section includes details on the market data sources, abbreviations and currencies codes used in this report.
Markets Covered:
By Product Type: Antibiotics, Antivirals, Antifungals and Others
Antibiotics is further segmented into ?-Lactams, Quinolones, Macrolides, Aminoglycosides and Others
Antivirals is further segmented into Hepatitis Therapeutics, Herpes Therapeutics, HIV AIDS Therapeutics and Influenza Therapeutics
Antifungals is further segmented into Azoles and Others
Companies Mentioned: Gilead Sciences, GlaxoSmithKline, Merck & Co, Teva Pharmaceutical Industries Ltd., Johnson & Johnson
Countries: China, Japan, India, Australia, Indonesia, Malaysia, New Zealand, Philippines, Singapore, South Korea, Thailand, Vietnam, Canada, Mexico, USA, Argentina, Brazil, Chile, Colombia, Peru, Venezuela,UK, Belgium, Denmark, Finland, France, Ireland, Italy, Netherlands, Norway, Portugal, Sweden , Switzerland, Germany, France, Spain, Czech Republic, Poland, Romania, Russia, Saudi Arabia, Israel, Turkey, UAE, Egypt, Nigeria, South Africa.
Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
TABLE OF CONTENTS
1. Anti-Infective Drugs Market Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Product Type
7. Anti-Infective Drugs Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Product Type
7.2.1. Antibiotics
7.2.2. Antivirals
7.2.3. Antifungals
7.2.4. Others (Anthelminthic, Antiprotozoal)
8. Anti-Infective Drugs Market Product Analysis
9. Anti-Infective Drugs Market Supply Chain Analysis
9.1. Raw Material Suppliers
9.2. Contract Research Organization (CRO)
9.3. Anti-Infective Drugs Manufacturer
9.4. Contract Manufacturing Organization (CMO)
9.5. Wholesalers/Distributors
9.6. Retailers (Pharmacies) And Hospitals
9.7. End-Users
10. Anti-Infective Drugs Market Customer Information
10.1. Willingness Towards Alternative Distribution And Dispensing Of Antiviral Drugs
10.2. Extensive Use Of Antibiotics In Low Income Countries
10.3. Anti-Parasitic Drugs May Improve Long Term Clinical Outcomes
10.4. Antifungal Drugs Are Widely Used By The Pediatric Population
10.5. Frequency Of Anti-Malarial Drug Use
10.6. High Proportion of Americans Consume Prescription Drugs
10.7. Consumers Find Generics As Good As Prescription Drugs
11. Anti-Infective Drugs Market Trends And Opportunities
11.1. Strategic Collaborations And Agreements
11.2. Demand For New Medicines For Drug-Resistant Infections
11.3. Global Research Initiatives And Funding
11.4. 3D Printing Technology
11.5. Termination Of R&D Pipelines Of Anti-Infective Drugs
11.6. Diversification Of Portfolios And Enhanced Focus On The Chronic Segment
11.7. Increasing Number Of Pipeline Studies And Drug Development
12. Anti-Infective Drugs Market Opportunity Assessment, PESTEL Analysis
12.1. Political
12.1.1. Government Initiatives
12.1.2. Political Uncertainties
12.2. Economic
12.2.1. Emerging Economies
12.2.2. Inflated Drug Prices
12.2.3. Rising Disposable Incomes
12.3. Social
12.3.1. Aging Global Population
12.3.2. Health Consciousness And Awareness
12.3.3. Shortages Of Human Resources
12.4. Technological
12.4.1. Internet Connectivity Rising Awareness
12.5. Environmental
12.6. Environmental Pollution
12.7. Natural Disasters
12.8. Legal
12.8.1. Stringent Regulations
12.8.2. Lengthy Drug Approval Processes
13. Global Anti-Infective Drugs Market Size And Growth
13.1. Market Size
13.2. Historic Market Growth, Value ($ Billion)
13.2.1. Drivers Of The Market 2014-18
13.2.1.1. Rise In Incidence Rates Of Infectious Diseases
13.2.1.2. Population Aging
13.2.1.3. Growth Of Emerging Markets
13.2.2. Restraints On The Market 2014-18
13.2.2.1. Patent Expiration Of Drugs
13.2.2.2. Low Returns On Investments
13.3. Forecast Market Growth, Value ($ Billion)
13.3.1. Drivers Of The Market 2018-22
13.3.1.1. Developments In Drug Discovery Procedures
13.3.1.2. Increase In The Sepsis Prevalence
13.3.1.3. Economic Growth
13.3.2. Restraints On The Market 2018-22
13.3.2.1. Increasing Antimicrobial Resistance
13.3.2.2. Supply Shortages Of Anti-Infective Drugs
13.3.2.3. Reductions In Free Trade
14. Anti-Infective Drugs Market Regional Analysis
14.1. Global Anti-Infective Drugs Market, 2018, By Region, Value ($ Billion)
14.2. Global Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Region
14.3. Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region
15. Global Anti-Infective Drugs Market Segmentation
15.1. Global Anti-Infective Drugs Market, Segmentation By Product Type, 2014 - 2022, Value ($ Billion)
15.2. Global Antibiotics Market, Segmentation By Product Type, 2014 - 2022, Value ($ Billion)
15.3. Global Antivirals Market, Segmentation By Therapeutic Type, 2014 - 2022, Value ($ Billion)
15.4. Global Antifungals Market, Segmentation By Product Type, 2014 - 2022, Value ($ Billion)
16. Global Anti-Infective Drugs Market Metrics
16.1. Anti-Infective Drugs Market Size, Percentage Of GDP, Global
16.2. Per Capita Average Anti-Infective Drugs Expenditure, Global
17. Asia-Pacific Anti-Infective Drugs Market
17.1. Asia-Pacific Anti-infective Drugs Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. Background Information
17.1.4. Government Initiatives
17.1.5. Regulations
17.1.6. Regulatory Bodies
17.1.7. Tax Levied
17.1.8. Associations
17.1.9. Corporate Tax Structure
17.1.10. Investments
17.1.11. Major Companies
17.2. Asia-Pacific Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
17.3. Asia-Pacific Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
17.4. Asia-Pacific Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
17.5. Asia-Pacific Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
17.6. Asia-Pacific Anti-Infective Drugs Market Metrics
17.7. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Asia-Pacific Countries
17.8. Asia-Pacific Anti-Infective Drugs Market: Country Analysis
17.8.1. Australia Anti-Infective Drugs Market
17.8.2. Australia Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
17.8.3. China Anti-Infective Drugs Market
17.8.3.1. China Anti-Infective Drugs Market Overview
17.8.3.1.1. Country Information
17.8.3.1.2. Market Information
17.8.3.1.3. Background Information
17.8.3.1.4. Government Initiatives
17.8.3.1.5. Regulations
17.8.3.1.6. Regulatory Bodies
17.8.3.1.7. Tax Levied
17.8.3.1.8. Associations
17.8.3.1.9. Corporate Tax Structure
17.8.3.1.10. Investments
17.8.3.1.11. Major Companies
17.8.3.2. China Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
17.8.4. Hong Kong Anti-Infective Drugs Market
17.8.4.1. Hong Kong Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.5. India Anti-Infective Drugs Market
17.8.6. India Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
17.8.7. Indonesia Anti-Infective Drugs Market
17.8.7.1. Indonesia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.8. Japan Anti-Infective Drugs Market
17.8.8.1. Japan Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
17.8.9. Malaysia Anti-Infective Drugs Market
17.8.10. Malaysia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.11. New Zealand Anti-Infective Drugs Market
17.8.12. New Zealand Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.13. Philippines Anti-Infective Drugs Market
17.8.13.1. Philippines Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.14. Singapore Anti-Infective Drugs Market
17.8.14.1. Singapore Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.15. South Korea Anti-Infective Drugs Market
17.8.16. South Korea Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.17. Thailand Anti-Infective Drugs Market
17.8.18. Thailand Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.19. Vietnam Anti-Infective Drugs Market
17.8.19.1. Vietnam Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18. Western Europe Anti-Infective Drugs Market
18.1. Western Europe Anti-infective Drugs Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. Background Information
18.1.4. Government Initiatives
18.1.5. Regulations
18.1.6. Regulatory Bodies
18.1.7. Tax Levied
18.1.8. Associations
18.1.9. Corporate Tax Structure
18.1.10. Investments
18.1.11. Major Companies
18.2. Western Europe Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
18.3. Western Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
18.4. Western Europe Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
18.5. Western Europe Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
18.6. Western Europe Anti-Infective Drugs Market Metrics
18.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Western Europe Countries
18.7. Western Europe Anti-Infective Drugs Market: Country Analysis
18.7.1. Austria Anti-Infective Drugs Market
18.7.1.1. Austria Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.2. Belgium Anti-Infective Drugs Market
18.7.2.1. Belgium Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.3. Denmark Anti-Infective Drugs Market
18.7.3.1. Denmark Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.4. Finland Anti-Infective Drugs Market
18.7.4.1. Finland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.5. France Anti-Infective Drugs Market
18.7.5.1. France Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
18.7.6. Germany Anti-Infective Drugs Market
18.7.6.1. Germany Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
18.7.7. Ireland Anti-Infective Drugs Market
18.7.7.1. Ireland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.8. Italy Anti-Infective Drugs Market
18.7.8.1. Italy Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
18.7.9. Netherlands Anti-Infective Drugs Market
18.7.9.1. Netherlands Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.10. Norway Anti-Infective Drugs Market
18.7.10.1. Norway Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.11. Portugal Anti-Infective Drugs Market
18.7.12. Portugal Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.13. Spain Anti-Infective Drugs Market
18.7.13.1. Spain Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
18.7.14. Sweden Anti-Infective Drugs Market
18.7.14.1. Sweden Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.15. Switzerland Anti-Infective Drugs Market
18.7.15.1. Switzerland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.16. UK Anti-Infective Drugs Market
18.7.16.1. UK Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
19. Eastern Europe Anti-Infective Drugs Market
19.1. Eastern Europe Anti-infective Drugs Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. Background Information
19.1.4. Government Initiatives
19.1.5. Regulations
19.1.6. Regulatory Bodies
19.1.7. Tax Levied
19.1.8. Associations
19.1.9. Corporate Tax Structure
19.1.10. Investments
19.1.11. Major Companies
19.2. Eastern Europe Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
19.3. Eastern Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
19.4. Eastern Europe Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
19.5. Eastern Europe Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
19.6. Eastern Europe Anti-Infective Drugs Market Metrics
19.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Eastern Europe Countries
19.7. Eastern Europe Anti-Infective Drugs Market: Country Analysis
19.7.1. Czech Republic Anti-Infective Drugs Market
19.7.1.1. Czech Republic Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
19.7.2. Poland Anti-Infective Drugs Market
19.7.2.1. Poland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
19.7.3. Romania Anti-Infective Drugs Market
19.7.3.1. Romania Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
19.7.4. Russia Anti-Infective Drugs Market
19.7.4.1. Russia Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
20. North America Anti-Infective Drugs Market
20.1. North America Anti-infective Drugs Market Overview
20.1.1. Region Information
20.1.2. Market Information
20.1.3. Background Information
20.1.4. Government Initiatives
20.1.5. Regulatory Bodies
20.1.6. Tax Levied
20.1.7. Associations
20.1.8. Corporate Tax Structure
20.1.9. Investments
20.1.10. Major Companies
20.2. North America Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
20.3. North America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
20.4. North America Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
20.5. Growth has slowed in most countries of the North America anti-infective drugs market, accelerating in Mexico.
20.6. North America Anti-Infective Drugs Market, 2018 - 2022, Growth And Market Share Comparison, By Country
20.7. North America Anti-Infective Drugs Market Metrics
20.7.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, North America Countries
20.8. North America Anti-Infective Drugs Market: Country Analysis
20.8.1. USA Anti-Infective Drugs Market
20.8.1.1. USA Anti-infective Drugs Market Overview
20.8.1.1.1. Country Information
20.8.1.1.2. Market Information
20.8.1.1.3. Background Information
20.8.1.1.4. Government Initiatives
20.8.1.1.5. Regulatory Bodies
20.8.1.1.6. Tax Levied
20.8.1.1.7. Associations
20.8.1.1.8. Corporate Tax Structure
20.8.1.1.9. Investments
20.8.1.1.10. Major Companies
20.8.1.2. USA Anti-Infective Drugs Market
20.8.1.3. USA Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
20.8.2. Canada Anti-Infective Drugs Market
20.8.2.1. Canada Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
20.8.3. Mexico Anti-Infective Drugs Market
20.8.4. Mexico Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
21. South America Anti-Infective Drugs Market
21.1. South America Anti-infective Drugs Market Overview
21.1.1. Region Information
21.1.2. Market Information
21.1.3. Background Information
21.1.4. Government Initiatives
21.1.5. Regulations
21.1.6. Regulatory Bodies
21.1.7. Tax Levied
21.1.8. Associations
21.1.9. Corporate Tax Structure
21.1.10. Investments
21.1.11. Major Companies
21.2. South America Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
21.3. South America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
21.4. South America Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
21.5. Growth has slowed in most counties of the South American anti-infective drugs market, accelerating in Colombia and Venezuela.
21.6. South America Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
21.7. South America Anti-Infective Drugs Market Metrics
21.7.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, South America Countries
21.8. South America Anti-Infective Drugs Market: Country Analysis
21.8.1. Argentina Anti-Infective Drugs Market
21.8.1.1. Argentina Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
21.8.2. Brazil Anti-Infective Drugs Market
21.8.2.1. Brazil Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
21.8.3. Chile Anti-Infective Drugs Market
21.8.3.1. Chile Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
21.8.4. Colombia Anti-Infective Drugs Market
21.8.4.1. Colombia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
21.8.5. Peru Anti-Infective Drugs Market
21.8.5.1. Peru Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
21.8.6. Venezuela Anti-Infective Drugs Market
21.8.6.1. Venezuela Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
22. Middle East Anti-Infective Drugs Market
22.1. Middle East Anti-infective Drugs Market Overview
22.1.1. Region Information
22.1.2. Market Information
22.1.3. Background Information
22.1.4. Government Initiatives
22.1.5. Regulatory Bodies
22.1.6. Tax Levied
22.1.7. Corporate Tax Structure
22.1.8. Investments
22.1.9. Major Companies
22.2. Middle East Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
22.3. Middle East Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
22.4. Middle East Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
22.5. Middle East Anti-Infective Drugs Market, 2018 - 2022, Growth And Market Share Comparison, By Country
22.6. Middle East Anti-Infective Drugs Market Metrics
22.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Middle East Countries
22.7. Middle East Anti-Infective Drugs Market: Country Analysis
22.7.1. Israel Anti-Infective Drugs Market
22.7.1.1. Israel Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
22.7.2. Saudi Arabia Anti-Infective Drugs Market
22.7.2.1. Saudi Arabia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
22.7.3. Turkey Anti-Infective Drugs Market
22.7.3.1. Turkey Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
22.7.4. UAE Anti-Infective Drugs Market
22.7.5. UAE Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
23. Africa Anti-Infective Drugs Market
23.1. Africa Anti-infective Drugs Market Overview
23.1.1. Region Information
23.1.2. Market Information
23.1.3. Background Information
23.1.4. Government Initiatives
23.1.5. Regulations
23.1.6. Regulatory Bodies
23.1.7. Tax Levied
23.1.8. Corporate Tax Structure
23.1.9. Investments
23.1.10. Major Companies
23.2. Africa Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
23.3. Africa Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
23.4. Africa Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
23.5. Africa Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
23.6. Africa Anti-Infective Drugs Market Metrics
23.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Africa Countries
23.7. Africa Anti-Infective Drugs Market: Country Analysis
23.7.1. Egypt Anti-Infective Drugs Market
23.7.1.1. Egypt Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
23.7.2. Nigeria Anti-Infective Drugs Market
23.7.2.1. Nigeria Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
23.7.3. South Africa Anti-Infective Drugs Market
23.7.4. South Africa Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
24. Global Anti-infective Drugs Market Competitive Landscape
24.1. Company Profiles
24.1.1. Gilead Sciences
24.1.1.1. Company Overview
24.1.1.2. Products And Services
24.1.1.3. Product Pipeline
24.1.1.4. Business Strategy
24.1.1.5. Financial Overview
24.1.2. GlaxoSmithKline
24.1.2.1. Company Overview
24.1.2.2. Products And Services
24.1.2.3. Product Pipeline
24.1.2.4. Business Strategy
24.1.2.5. Financial Overview
24.1.3. Merck & Co
24.1.3.1. Company Overview
24.1.3.2. Products And Services
24.1.3.3. Product Pipeline
24.1.3.4. Business Strategy
24.1.3.5. Financial Overview
24.1.4. Teva Pharmaceutical Industries Ltd.
24.1.4.1. Company Overview
24.1.4.2. Products And Services
24.1.4.3. Business Strategy
24.1.4.4. Financial Overview
24.1.5. Johnson & Johnson
24.1.5.1. Company Overview
24.1.5.2. Products And Services
24.1.5.3. Product Pipeline
24.1.5.4. Business Strategy
24.1.5.5. Financial Overview
25. Anti-Infective Drugs Market, Key Mergers And Acquisitions
25.1. Cumberaland Pharmaceuticals Acquired Anti- Infective Injection Business Of Theravance Biopharma
25.2. Boston Pharmaceuticals Acquired Novartis Three Novel Anti-Infective Drugs
25.3. Boston Pharmaceuticals Acquired Five Development Programs From GlaxoSmithKline
25.4. Redx Pharma Signned An Option Deal For Anti-Infective Program With Deinove
25.5. Melinta Therapeutics Acquired The Medicines Companys Infectious Disease Portfolio
25.6. Melinta Therapeutics Merged With Cempra
25.7. Pfizer Acquired Small Molecule Anti-Infective Business From AstraZeneca
25.8. Citius Pharmaceuticals Acquired Leonard-Meron Biosciences
25.9. Johnson & Johnson Acquired Novira Therapeutics, Inc.
25.10. Johnson & Johnson Acquired Alios
26. Market Background: Pharmaceutical Drugs Market
26.1. Pharmaceutical Drugs Market Characteristics
26.2. Market Segmentation By Product Type
26.2.1. Musculoskeletal Drugs
26.2.2. Cardiovascular Drugs
26.2.3. Oncology Drugs
26.2.4. Anti-Infective Drugs
26.2.5. Metabolic Disorders Drugs
26.2.6. Central Nervous System Drugs
26.2.7. Genito-Urinary Drugs
26.2.8. Respiratory Diseases Drugs
26.2.9. Gastrointestinal Drugs
26.2.10. Hematology Drugs
26.2.11. Dermatology Drugs
26.2.12. Ophthalmology Drugs
26.2.13. Pharmaceutical Drugs Market Segmentation
26.3. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
26.4. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
26.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
27. Global Anti-Infective Drugs Market Opportunities And Strategies
27.1. Global Anti-Infective Drugs Market In 2022 Countries Offering Most New Opportunities
27.2. Global Anti-Infective Drugs Market In 2022 Segments Offering Most New Opportunities
27.3. Global Antibiotics Market In 2022 Sub-Segments Offering Most New Opportunities
27.3.1. Global Antifungals Market In 2022 Sub-Segments Offering Most New Opportunities
27.3.2. Global Antivirals Market In 2022 Sub-Segments Offering Most New Opportunities
27.4. Global Anti-Infective Drugs Market In 2022 Growth Strategies
27.4.1. Market Trend Based Strategies
27.4.2. Competitor Strategies
28. Anti-Infective Drugs Market, Conclusions And Recommendations
28.1. Conclusions
28.2. Recommendations
28.2.1. Product
28.2.2. Price
28.2.3. Place
28.2.4. Promotion
28.2.5. People
29. Appendix
29.1. Market Data Sources
29.2. Research Methodology
29.3. Currencies
29.4. Research Inquiries
29.5. The Business Research Company
29.6. Copyright and Disclaimer
Table 2: Global Anti-Infective Drugs Market, Historic Market Size, 2014 2018, $ Billion
Table 3: Global Anti-Infective Drugs Market, Forecast Market Size, 2018 2022, $ Billion
Table 4: Global Anti-Infective Drugs Market, 2018, Split By Region
Table 5: Global Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, Split By Region
Table 6: Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region
Table 7: Global Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 8: Global Antibiotics Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 9: Global Antivirals Market, Segmentation By Therapeutic Type, 2014-2022, $ Billion
Table 10: Global Antifungals Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 11: Global Anti-Infective Drugs Market Value, Market Size As A Percentage Of Global GDP, 2014 2022
Table 12: Global Anti-Infective Drugs Market, Per Capita Average Anti-Infective Drugs Expenditure, 2014-2022, ($)
Table 13: Asia-Pacific, Defined Daily Dosage Per 1000 Inhabitants Per Day, 2013-2016
Table 14:Asia-Pacific, Number Of Buruli Ulcer Cases, 2013-2017
Table 15: Asia-Pacific, Trends In Indigenous Malaria Cases, 2013-2017
Table 16: Asia-Pacific Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 17: Asia-Pacific Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Table 18: Asia-Pacific Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Table 19: Asia-Pacific Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Table 20: Asia-Pacific Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
Table 21: Australia Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 22: China Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 23: Hong Kong Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 24: India Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 25: Indonesia Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 26: Japan Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 27: Malaysia Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 28: New Zealand Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 29: Philippines Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 30: Singapore Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 31: South Korea Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 32: Thailand Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 33: Vietnam Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 34: Western Europe, Defined Daily Dosage Per 1000 Inhabitants Per Day, 2013-2017
Table 35: Corporate Tax Structure In Western Europe Countries, %
Table 36: Western Europe Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 37: Western Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Table 38: Western Europe Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Table 39: Western Europe Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Table 40: Western Europe Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
Table 41: Austria Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 42: Belgium Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 43: Denmark Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 44: Finland Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 45: France Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 46: Germany Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 47: Ireland Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 48: Italy Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 49: Netherlands Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 50: Norway Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 51: Portugal Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 52: Spain Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 53: Sweden Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 54: Switzerland Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 55: UK Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 56: Eastern Europe, Defined Daily Dosage Per 1000 Inhabitants Per Day, 2013-2017
Table 57: Eastern Europe Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 58: Eastern Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Table 59: Eastern Europe Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Table 60: Eastern Europe Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Table 61: Eastern Europe Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
Table 62: Czech Republic Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 63: Poland Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 64: Romania Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 65: Russia Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 66: South America, Defined Daily Doses (DDD) Per 1,000 Inhabitants Per Day, 2013 2017
Table 67: North America Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 68: North America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Table 69: North America Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Table 70: North America Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Table 71: North America Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
Table 72: USA Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 73: Canada Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 74: Mexico Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 75: South America, Defined Daily Doses (DDD) Per 1,000 Individuals, 2015
Table 76: South America, Estimated Number Of Individuals In The Country Requiring Preventive Chemotherapy For Onchocerciasis, 2013 2017
Table 77: South America, Reported Number Of Individuals Treated For Onchocerciasis, 2013 2017
Table 78: South America Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 79: South America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Table 80: South America Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Table 81: South America Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Table 82: South America Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
Table 83: Argentina Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 84: Brazil Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 85: Chile Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 86: Colombia Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 87: Peru Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 88: Venezuela Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 89: Middle East, Defined Daily Doses (DDD) Per 1,000 Individuals, 2015
Table 90: Middle East, Estimated Number Of Individuals In The Country Requiring Preventive Chemotherapy For Onchocerciasis, 2013 2017
Table 91: Middle East, Reported Number Of Individuals Treated For Onchocerciasis, 2013 2017
Table 92: Middle East, Trends In Indigenous Malaria Cases, 2013 2017
Table 93: Middle East Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 94: Middle East Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Table 95: Middle East Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Table 96: Middle East Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Table 97: Middle East Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
Table 98: Israel Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 99: Saudi Arabia Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 100: Turkey Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 101: UAE Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 102: Africa, Defined Daily Doses (DDD) Per 1,000 Individuals, 2015
Table 103: Africa, Number Of Buruli Ulcer Cases, 2013 2017
Table 104: Africa, Estimated Number Of Individuals In The Country Requiring Preventive Chemotherapy For Onchocerciasis, 2013 2017
Table 105: Africa, Reported Number Of Individuals Treated For Onchocerciasis, 2013 2017
Table 106: Africa, Trends In Indigenous Malaria Cases, 2013 2017
Table 107: Africa Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 108: Africa Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Table 109: Africa Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Table 110: Africa Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Table 111: Africa Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
Table 112: Egypt Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 113: Nigeria Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 114: South Africa Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 115: Global Anti-infective Drugs Market, Key Competitor Estimated Market Shares, 2018, Percentage (%)
Table 116: Other Major Competitors In The Global Anti-infective Drugs Market
Table 117: Gilead Sciences Anti-infective Drugs In Pipeline
Table 118: Gilead Sciences Financial Performance, $ Billion
Table 119: Gilead Sciences Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Table 120: GlaxoSmithKline plc Anti-infective Drugs In Pipeline
Table 121: GlaxoSmithKline Financial Performance, $ Billion
Table 122: GlaxoSmithKline Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Table 123: Merck & Co Anti-infective Drugs In Pipeline
Table 124: Merck & Co. Financial Performance, $ Billion
Table 125: Merck & Co. Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Table 126: Teva Pharmaceutical Industries Ltd. Financial Performance, $ Billion
Table 127: Teva Pharmaceutical Industries Ltd. Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Table 128: Johnson & Johnson Anti-infective Drugs In Pipeline
Table 129: Johnson & Johnson Financial Performance, $ Billion
Table 130: Johnson & Johnson Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Table 131: Global Pharmaceutical Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 132: Global Pharmaceutical Drugs Market, 2018, Split By Region
Table 133: Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast Growth Rate, Split By Region
Table 134: Global Anti-Infective Drugs Market Size Gain ($ Billion), 2018 2022, By Country
Table 135: Global Anti-Infective Drugs Market Size Gain ($ Billion), 2018 2022, By Segment
Table 136: Global Antibiotics Market Size Gain ($ Billion), 2018 2022, By Segment
Table 137: Global Antifungals Market Size Gain ($ Billion), 2018 2022, By Segment
Table 138: Global Antivirals Market Size Gain ($ Billion), 2018 2022, By Segment
Table 139: Anti-Infective Drugs Market Data Sources
Figure 2: Global Anti-Infective Drugs Industry, Supply Chain Analysis
Figure 3: Global Anti-Infective Drugs Market, PESTEL Analysis
Figure 4: Global Anti-Infective Drugs Market, Historic Market Size, 2014-2018, $ Billion
Figure 5: Global Anti-Infective Drugs Market, Forecast Market Size, 2018-2022, $ Billion
Figure 6: Global Anti-Infective Drugs Market, 2018, Split By Region
Figure 7: Global Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, Split By Region
Figure 8: Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region
Figure 9: Global Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 10: Global Antibiotics Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 11: Global Antivirals Market, Segmentation By Therapeutic Type, 2014-2022, $ Billion
Figure 12: Global Antifungals Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 13: Asia-Pacific Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 14: Asia-Pacific Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Figure 15: Asia-Pacific Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Figure 16: Asia-Pacific Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Figure 17: Australia Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 18: China Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 19: Hong Kong Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 20: India Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 21: Indonesia Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 22: Japan Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 23: Malaysia Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 24: New Zealand Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 25: Philipines Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 26: Singapore Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 27: South Korea Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 28: Thailand Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 29: Vietnam Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 30: Western Europe Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 31: Western Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Figure 32: Western Europe Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Figure 33: Western Europe Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Figure 34: Austria Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 35: Belgium Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 36: Denmark Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 37: Finland Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 38: France Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 39: Germany Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 40: Ireland Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 41: Italy Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 42: Netherlands Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 43: Norway Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 44: Portugal Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 45: Spain Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 46: Sweden Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 47: Switzerland Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 48: UK Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 49: Eastern Europe Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 50: Eastern Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Figure 51: Eastern Europe Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Figure 52: Eastern Europe Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Figure 53: Czech Republic Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 54: Romania Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 55: Romania Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 56: Russia Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 57: North America Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 58: North America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Figure 59: North America Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Figure 60: North America Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Figure 61: USA Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 62: Canada Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 63: Mexico Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 64: South America Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 65: South America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Figure 66: South America Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Figure 67: South America Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Figure 68: Argentina Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 69: Brazil Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 70: Chile Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 71: Colombia Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 72: Peru Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 73: Venezuela Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 74: Middle East Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 75: Middle East Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Figure 76: Middle East Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Figure 77: Middle East Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Figure 78: Israel Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 79: Saudi Arabia Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 80: Turkey Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 81: UAE Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 82: Africa Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 83: Africa Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Figure 84: Africa Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Figure 85: Africa Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Figure 86: Egypt Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 87: Nigeria Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 88: South Africa Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 89: Global Anti-infective Drugs Market, Key Competitor Estimated Market Shares, 2018, Percentage (%)
Figure 90: Gilead Sciences Financial Performance, $ Billion
Figure 91: Gilead Sciences Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Figure 92: GlaxoSmithKline Financial Performance, $ Billion
Figure 93: GlaxoSmithKline Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Figure 94: Merck & Co. Financial Performance, $ Billion
Figure 95: Merck & Co. Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Figure 96: Teva Pharmaceutical Industries Ltd. Financial Performance, $ Billion
Figure 97: Teva Pharmaceutical Industries Ltd. Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Figure 98: Johnson & Johnson Financial Performance, $ Billion
Figure 99: Johnson & Johnson Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Figure 100: Global Pharmaceutical Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 101: Global Pharmaceutical Drugs Market, 2018, Split By Region
Figure 102: Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast Growth Rate, Split By Region
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Product Type
7. Anti-Infective Drugs Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Product Type
7.2.1. Antibiotics
7.2.2. Antivirals
7.2.3. Antifungals
7.2.4. Others (Anthelminthic, Antiprotozoal)
8. Anti-Infective Drugs Market Product Analysis
9. Anti-Infective Drugs Market Supply Chain Analysis
9.1. Raw Material Suppliers
9.2. Contract Research Organization (CRO)
9.3. Anti-Infective Drugs Manufacturer
9.4. Contract Manufacturing Organization (CMO)
9.5. Wholesalers/Distributors
9.6. Retailers (Pharmacies) And Hospitals
9.7. End-Users
10. Anti-Infective Drugs Market Customer Information
10.1. Willingness Towards Alternative Distribution And Dispensing Of Antiviral Drugs
10.2. Extensive Use Of Antibiotics In Low Income Countries
10.3. Anti-Parasitic Drugs May Improve Long Term Clinical Outcomes
10.4. Antifungal Drugs Are Widely Used By The Pediatric Population
10.5. Frequency Of Anti-Malarial Drug Use
10.6. High Proportion of Americans Consume Prescription Drugs
10.7. Consumers Find Generics As Good As Prescription Drugs
11. Anti-Infective Drugs Market Trends And Opportunities
11.1. Strategic Collaborations And Agreements
11.2. Demand For New Medicines For Drug-Resistant Infections
11.3. Global Research Initiatives And Funding
11.4. 3D Printing Technology
11.5. Termination Of R&D Pipelines Of Anti-Infective Drugs
11.6. Diversification Of Portfolios And Enhanced Focus On The Chronic Segment
11.7. Increasing Number Of Pipeline Studies And Drug Development
12. Anti-Infective Drugs Market Opportunity Assessment, PESTEL Analysis
12.1. Political
12.1.1. Government Initiatives
12.1.2. Political Uncertainties
12.2. Economic
12.2.1. Emerging Economies
12.2.2. Inflated Drug Prices
12.2.3. Rising Disposable Incomes
12.3. Social
12.3.1. Aging Global Population
12.3.2. Health Consciousness And Awareness
12.3.3. Shortages Of Human Resources
12.4. Technological
12.4.1. Internet Connectivity Rising Awareness
12.5. Environmental
12.6. Environmental Pollution
12.7. Natural Disasters
12.8. Legal
12.8.1. Stringent Regulations
12.8.2. Lengthy Drug Approval Processes
13. Global Anti-Infective Drugs Market Size And Growth
13.1. Market Size
13.2. Historic Market Growth, Value ($ Billion)
13.2.1. Drivers Of The Market 2014-18
13.2.1.1. Rise In Incidence Rates Of Infectious Diseases
13.2.1.2. Population Aging
13.2.1.3. Growth Of Emerging Markets
13.2.2. Restraints On The Market 2014-18
13.2.2.1. Patent Expiration Of Drugs
13.2.2.2. Low Returns On Investments
13.3. Forecast Market Growth, Value ($ Billion)
13.3.1. Drivers Of The Market 2018-22
13.3.1.1. Developments In Drug Discovery Procedures
13.3.1.2. Increase In The Sepsis Prevalence
13.3.1.3. Economic Growth
13.3.2. Restraints On The Market 2018-22
13.3.2.1. Increasing Antimicrobial Resistance
13.3.2.2. Supply Shortages Of Anti-Infective Drugs
13.3.2.3. Reductions In Free Trade
14. Anti-Infective Drugs Market Regional Analysis
14.1. Global Anti-Infective Drugs Market, 2018, By Region, Value ($ Billion)
14.2. Global Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Region
14.3. Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region
15. Global Anti-Infective Drugs Market Segmentation
15.1. Global Anti-Infective Drugs Market, Segmentation By Product Type, 2014 - 2022, Value ($ Billion)
15.2. Global Antibiotics Market, Segmentation By Product Type, 2014 - 2022, Value ($ Billion)
15.3. Global Antivirals Market, Segmentation By Therapeutic Type, 2014 - 2022, Value ($ Billion)
15.4. Global Antifungals Market, Segmentation By Product Type, 2014 - 2022, Value ($ Billion)
16. Global Anti-Infective Drugs Market Metrics
16.1. Anti-Infective Drugs Market Size, Percentage Of GDP, Global
16.2. Per Capita Average Anti-Infective Drugs Expenditure, Global
17. Asia-Pacific Anti-Infective Drugs Market
17.1. Asia-Pacific Anti-infective Drugs Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. Background Information
17.1.4. Government Initiatives
17.1.5. Regulations
17.1.6. Regulatory Bodies
17.1.7. Tax Levied
17.1.8. Associations
17.1.9. Corporate Tax Structure
17.1.10. Investments
17.1.11. Major Companies
17.2. Asia-Pacific Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
17.3. Asia-Pacific Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
17.4. Asia-Pacific Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
17.5. Asia-Pacific Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
17.6. Asia-Pacific Anti-Infective Drugs Market Metrics
17.7. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Asia-Pacific Countries
17.8. Asia-Pacific Anti-Infective Drugs Market: Country Analysis
17.8.1. Australia Anti-Infective Drugs Market
17.8.2. Australia Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
17.8.3. China Anti-Infective Drugs Market
17.8.3.1. China Anti-Infective Drugs Market Overview
17.8.3.1.1. Country Information
17.8.3.1.2. Market Information
17.8.3.1.3. Background Information
17.8.3.1.4. Government Initiatives
17.8.3.1.5. Regulations
17.8.3.1.6. Regulatory Bodies
17.8.3.1.7. Tax Levied
17.8.3.1.8. Associations
17.8.3.1.9. Corporate Tax Structure
17.8.3.1.10. Investments
17.8.3.1.11. Major Companies
17.8.3.2. China Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
17.8.4. Hong Kong Anti-Infective Drugs Market
17.8.4.1. Hong Kong Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.5. India Anti-Infective Drugs Market
17.8.6. India Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
17.8.7. Indonesia Anti-Infective Drugs Market
17.8.7.1. Indonesia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.8. Japan Anti-Infective Drugs Market
17.8.8.1. Japan Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
17.8.9. Malaysia Anti-Infective Drugs Market
17.8.10. Malaysia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.11. New Zealand Anti-Infective Drugs Market
17.8.12. New Zealand Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.13. Philippines Anti-Infective Drugs Market
17.8.13.1. Philippines Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.14. Singapore Anti-Infective Drugs Market
17.8.14.1. Singapore Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.15. South Korea Anti-Infective Drugs Market
17.8.16. South Korea Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.17. Thailand Anti-Infective Drugs Market
17.8.18. Thailand Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
17.8.19. Vietnam Anti-Infective Drugs Market
17.8.19.1. Vietnam Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18. Western Europe Anti-Infective Drugs Market
18.1. Western Europe Anti-infective Drugs Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. Background Information
18.1.4. Government Initiatives
18.1.5. Regulations
18.1.6. Regulatory Bodies
18.1.7. Tax Levied
18.1.8. Associations
18.1.9. Corporate Tax Structure
18.1.10. Investments
18.1.11. Major Companies
18.2. Western Europe Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
18.3. Western Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
18.4. Western Europe Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
18.5. Western Europe Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
18.6. Western Europe Anti-Infective Drugs Market Metrics
18.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Western Europe Countries
18.7. Western Europe Anti-Infective Drugs Market: Country Analysis
18.7.1. Austria Anti-Infective Drugs Market
18.7.1.1. Austria Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.2. Belgium Anti-Infective Drugs Market
18.7.2.1. Belgium Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.3. Denmark Anti-Infective Drugs Market
18.7.3.1. Denmark Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.4. Finland Anti-Infective Drugs Market
18.7.4.1. Finland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.5. France Anti-Infective Drugs Market
18.7.5.1. France Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
18.7.6. Germany Anti-Infective Drugs Market
18.7.6.1. Germany Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
18.7.7. Ireland Anti-Infective Drugs Market
18.7.7.1. Ireland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.8. Italy Anti-Infective Drugs Market
18.7.8.1. Italy Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
18.7.9. Netherlands Anti-Infective Drugs Market
18.7.9.1. Netherlands Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.10. Norway Anti-Infective Drugs Market
18.7.10.1. Norway Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.11. Portugal Anti-Infective Drugs Market
18.7.12. Portugal Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.13. Spain Anti-Infective Drugs Market
18.7.13.1. Spain Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
18.7.14. Sweden Anti-Infective Drugs Market
18.7.14.1. Sweden Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.15. Switzerland Anti-Infective Drugs Market
18.7.15.1. Switzerland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
18.7.16. UK Anti-Infective Drugs Market
18.7.16.1. UK Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
19. Eastern Europe Anti-Infective Drugs Market
19.1. Eastern Europe Anti-infective Drugs Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. Background Information
19.1.4. Government Initiatives
19.1.5. Regulations
19.1.6. Regulatory Bodies
19.1.7. Tax Levied
19.1.8. Associations
19.1.9. Corporate Tax Structure
19.1.10. Investments
19.1.11. Major Companies
19.2. Eastern Europe Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
19.3. Eastern Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
19.4. Eastern Europe Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
19.5. Eastern Europe Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
19.6. Eastern Europe Anti-Infective Drugs Market Metrics
19.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Eastern Europe Countries
19.7. Eastern Europe Anti-Infective Drugs Market: Country Analysis
19.7.1. Czech Republic Anti-Infective Drugs Market
19.7.1.1. Czech Republic Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
19.7.2. Poland Anti-Infective Drugs Market
19.7.2.1. Poland Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
19.7.3. Romania Anti-Infective Drugs Market
19.7.3.1. Romania Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
19.7.4. Russia Anti-Infective Drugs Market
19.7.4.1. Russia Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
20. North America Anti-Infective Drugs Market
20.1. North America Anti-infective Drugs Market Overview
20.1.1. Region Information
20.1.2. Market Information
20.1.3. Background Information
20.1.4. Government Initiatives
20.1.5. Regulatory Bodies
20.1.6. Tax Levied
20.1.7. Associations
20.1.8. Corporate Tax Structure
20.1.9. Investments
20.1.10. Major Companies
20.2. North America Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
20.3. North America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
20.4. North America Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
20.5. Growth has slowed in most countries of the North America anti-infective drugs market, accelerating in Mexico.
20.6. North America Anti-Infective Drugs Market, 2018 - 2022, Growth And Market Share Comparison, By Country
20.7. North America Anti-Infective Drugs Market Metrics
20.7.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, North America Countries
20.8. North America Anti-Infective Drugs Market: Country Analysis
20.8.1. USA Anti-Infective Drugs Market
20.8.1.1. USA Anti-infective Drugs Market Overview
20.8.1.1.1. Country Information
20.8.1.1.2. Market Information
20.8.1.1.3. Background Information
20.8.1.1.4. Government Initiatives
20.8.1.1.5. Regulatory Bodies
20.8.1.1.6. Tax Levied
20.8.1.1.7. Associations
20.8.1.1.8. Corporate Tax Structure
20.8.1.1.9. Investments
20.8.1.1.10. Major Companies
20.8.1.2. USA Anti-Infective Drugs Market
20.8.1.3. USA Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
20.8.2. Canada Anti-Infective Drugs Market
20.8.2.1. Canada Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
20.8.3. Mexico Anti-Infective Drugs Market
20.8.4. Mexico Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
21. South America Anti-Infective Drugs Market
21.1. South America Anti-infective Drugs Market Overview
21.1.1. Region Information
21.1.2. Market Information
21.1.3. Background Information
21.1.4. Government Initiatives
21.1.5. Regulations
21.1.6. Regulatory Bodies
21.1.7. Tax Levied
21.1.8. Associations
21.1.9. Corporate Tax Structure
21.1.10. Investments
21.1.11. Major Companies
21.2. South America Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
21.3. South America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
21.4. South America Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
21.5. Growth has slowed in most counties of the South American anti-infective drugs market, accelerating in Colombia and Venezuela.
21.6. South America Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
21.7. South America Anti-Infective Drugs Market Metrics
21.7.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, South America Countries
21.8. South America Anti-Infective Drugs Market: Country Analysis
21.8.1. Argentina Anti-Infective Drugs Market
21.8.1.1. Argentina Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
21.8.2. Brazil Anti-Infective Drugs Market
21.8.2.1. Brazil Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
21.8.3. Chile Anti-Infective Drugs Market
21.8.3.1. Chile Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
21.8.4. Colombia Anti-Infective Drugs Market
21.8.4.1. Colombia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
21.8.5. Peru Anti-Infective Drugs Market
21.8.5.1. Peru Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
21.8.6. Venezuela Anti-Infective Drugs Market
21.8.6.1. Venezuela Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
22. Middle East Anti-Infective Drugs Market
22.1. Middle East Anti-infective Drugs Market Overview
22.1.1. Region Information
22.1.2. Market Information
22.1.3. Background Information
22.1.4. Government Initiatives
22.1.5. Regulatory Bodies
22.1.6. Tax Levied
22.1.7. Corporate Tax Structure
22.1.8. Investments
22.1.9. Major Companies
22.2. Middle East Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
22.3. Middle East Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
22.4. Middle East Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
22.5. Middle East Anti-Infective Drugs Market, 2018 - 2022, Growth And Market Share Comparison, By Country
22.6. Middle East Anti-Infective Drugs Market Metrics
22.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Middle East Countries
22.7. Middle East Anti-Infective Drugs Market: Country Analysis
22.7.1. Israel Anti-Infective Drugs Market
22.7.1.1. Israel Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
22.7.2. Saudi Arabia Anti-Infective Drugs Market
22.7.2.1. Saudi Arabia Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
22.7.3. Turkey Anti-Infective Drugs Market
22.7.3.1. Turkey Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
22.7.4. UAE Anti-Infective Drugs Market
22.7.5. UAE Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
23. Africa Anti-Infective Drugs Market
23.1. Africa Anti-infective Drugs Market Overview
23.1.1. Region Information
23.1.2. Market Information
23.1.3. Background Information
23.1.4. Government Initiatives
23.1.5. Regulations
23.1.6. Regulatory Bodies
23.1.7. Tax Levied
23.1.8. Corporate Tax Structure
23.1.9. Investments
23.1.10. Major Companies
23.2. Africa Anti-Infective Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
23.3. Africa Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
23.4. Africa Anti-Infective Drugs Market, 2014 - 2022, Historic And Forecast, By Country
23.5. Africa Anti-Infective Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
23.6. Africa Anti-Infective Drugs Market Metrics
23.6.1. Per Capita Average Anti-Infective Drugs Expenditure, 2018, Africa Countries
23.7. Africa Anti-Infective Drugs Market: Country Analysis
23.7.1. Egypt Anti-Infective Drugs Market
23.7.1.1. Egypt Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
23.7.2. Nigeria Anti-Infective Drugs Market
23.7.2.1. Nigeria Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
23.7.3. South Africa Anti-Infective Drugs Market
23.7.4. South Africa Anti-Infective Drugs Market, 2014 - 2022, Value ($ Billion)
24. Global Anti-infective Drugs Market Competitive Landscape
24.1. Company Profiles
24.1.1. Gilead Sciences
24.1.1.1. Company Overview
24.1.1.2. Products And Services
24.1.1.3. Product Pipeline
24.1.1.4. Business Strategy
24.1.1.5. Financial Overview
24.1.2. GlaxoSmithKline
24.1.2.1. Company Overview
24.1.2.2. Products And Services
24.1.2.3. Product Pipeline
24.1.2.4. Business Strategy
24.1.2.5. Financial Overview
24.1.3. Merck & Co
24.1.3.1. Company Overview
24.1.3.2. Products And Services
24.1.3.3. Product Pipeline
24.1.3.4. Business Strategy
24.1.3.5. Financial Overview
24.1.4. Teva Pharmaceutical Industries Ltd.
24.1.4.1. Company Overview
24.1.4.2. Products And Services
24.1.4.3. Business Strategy
24.1.4.4. Financial Overview
24.1.5. Johnson & Johnson
24.1.5.1. Company Overview
24.1.5.2. Products And Services
24.1.5.3. Product Pipeline
24.1.5.4. Business Strategy
24.1.5.5. Financial Overview
25. Anti-Infective Drugs Market, Key Mergers And Acquisitions
25.1. Cumberaland Pharmaceuticals Acquired Anti- Infective Injection Business Of Theravance Biopharma
25.2. Boston Pharmaceuticals Acquired Novartis Three Novel Anti-Infective Drugs
25.3. Boston Pharmaceuticals Acquired Five Development Programs From GlaxoSmithKline
25.4. Redx Pharma Signned An Option Deal For Anti-Infective Program With Deinove
25.5. Melinta Therapeutics Acquired The Medicines Companys Infectious Disease Portfolio
25.6. Melinta Therapeutics Merged With Cempra
25.7. Pfizer Acquired Small Molecule Anti-Infective Business From AstraZeneca
25.8. Citius Pharmaceuticals Acquired Leonard-Meron Biosciences
25.9. Johnson & Johnson Acquired Novira Therapeutics, Inc.
25.10. Johnson & Johnson Acquired Alios
26. Market Background: Pharmaceutical Drugs Market
26.1. Pharmaceutical Drugs Market Characteristics
26.2. Market Segmentation By Product Type
26.2.1. Musculoskeletal Drugs
26.2.2. Cardiovascular Drugs
26.2.3. Oncology Drugs
26.2.4. Anti-Infective Drugs
26.2.5. Metabolic Disorders Drugs
26.2.6. Central Nervous System Drugs
26.2.7. Genito-Urinary Drugs
26.2.8. Respiratory Diseases Drugs
26.2.9. Gastrointestinal Drugs
26.2.10. Hematology Drugs
26.2.11. Dermatology Drugs
26.2.12. Ophthalmology Drugs
26.2.13. Pharmaceutical Drugs Market Segmentation
26.3. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Product Type, Value ($ Billion)
26.4. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
26.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
27. Global Anti-Infective Drugs Market Opportunities And Strategies
27.1. Global Anti-Infective Drugs Market In 2022 Countries Offering Most New Opportunities
27.2. Global Anti-Infective Drugs Market In 2022 Segments Offering Most New Opportunities
27.3. Global Antibiotics Market In 2022 Sub-Segments Offering Most New Opportunities
27.3.1. Global Antifungals Market In 2022 Sub-Segments Offering Most New Opportunities
27.3.2. Global Antivirals Market In 2022 Sub-Segments Offering Most New Opportunities
27.4. Global Anti-Infective Drugs Market In 2022 Growth Strategies
27.4.1. Market Trend Based Strategies
27.4.2. Competitor Strategies
28. Anti-Infective Drugs Market, Conclusions And Recommendations
28.1. Conclusions
28.2. Recommendations
28.2.1. Product
28.2.2. Price
28.2.3. Place
28.2.4. Promotion
28.2.5. People
29. Appendix
29.1. Market Data Sources
29.2. Research Methodology
29.3. Currencies
29.4. Research Inquiries
29.5. The Business Research Company
29.6. Copyright and Disclaimer
List Of Tables
Table 1: Anti-Infective Drugs Market Product Analysis Product ExamplesTable 2: Global Anti-Infective Drugs Market, Historic Market Size, 2014 2018, $ Billion
Table 3: Global Anti-Infective Drugs Market, Forecast Market Size, 2018 2022, $ Billion
Table 4: Global Anti-Infective Drugs Market, 2018, Split By Region
Table 5: Global Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, Split By Region
Table 6: Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region
Table 7: Global Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 8: Global Antibiotics Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 9: Global Antivirals Market, Segmentation By Therapeutic Type, 2014-2022, $ Billion
Table 10: Global Antifungals Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 11: Global Anti-Infective Drugs Market Value, Market Size As A Percentage Of Global GDP, 2014 2022
Table 12: Global Anti-Infective Drugs Market, Per Capita Average Anti-Infective Drugs Expenditure, 2014-2022, ($)
Table 13: Asia-Pacific, Defined Daily Dosage Per 1000 Inhabitants Per Day, 2013-2016
Table 14:Asia-Pacific, Number Of Buruli Ulcer Cases, 2013-2017
Table 15: Asia-Pacific, Trends In Indigenous Malaria Cases, 2013-2017
Table 16: Asia-Pacific Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 17: Asia-Pacific Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Table 18: Asia-Pacific Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Table 19: Asia-Pacific Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Table 20: Asia-Pacific Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
Table 21: Australia Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 22: China Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 23: Hong Kong Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 24: India Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 25: Indonesia Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 26: Japan Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 27: Malaysia Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 28: New Zealand Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 29: Philippines Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 30: Singapore Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 31: South Korea Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 32: Thailand Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 33: Vietnam Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 34: Western Europe, Defined Daily Dosage Per 1000 Inhabitants Per Day, 2013-2017
Table 35: Corporate Tax Structure In Western Europe Countries, %
Table 36: Western Europe Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 37: Western Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Table 38: Western Europe Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Table 39: Western Europe Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Table 40: Western Europe Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
Table 41: Austria Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 42: Belgium Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 43: Denmark Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 44: Finland Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 45: France Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 46: Germany Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 47: Ireland Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 48: Italy Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 49: Netherlands Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 50: Norway Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 51: Portugal Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 52: Spain Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 53: Sweden Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 54: Switzerland Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 55: UK Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 56: Eastern Europe, Defined Daily Dosage Per 1000 Inhabitants Per Day, 2013-2017
Table 57: Eastern Europe Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 58: Eastern Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Table 59: Eastern Europe Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Table 60: Eastern Europe Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Table 61: Eastern Europe Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
Table 62: Czech Republic Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 63: Poland Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 64: Romania Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 65: Russia Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 66: South America, Defined Daily Doses (DDD) Per 1,000 Inhabitants Per Day, 2013 2017
Table 67: North America Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 68: North America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Table 69: North America Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Table 70: North America Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Table 71: North America Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
Table 72: USA Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 73: Canada Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 74: Mexico Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 75: South America, Defined Daily Doses (DDD) Per 1,000 Individuals, 2015
Table 76: South America, Estimated Number Of Individuals In The Country Requiring Preventive Chemotherapy For Onchocerciasis, 2013 2017
Table 77: South America, Reported Number Of Individuals Treated For Onchocerciasis, 2013 2017
Table 78: South America Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 79: South America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Table 80: South America Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Table 81: South America Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Table 82: South America Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
Table 83: Argentina Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 84: Brazil Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 85: Chile Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 86: Colombia Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 87: Peru Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 88: Venezuela Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 89: Middle East, Defined Daily Doses (DDD) Per 1,000 Individuals, 2015
Table 90: Middle East, Estimated Number Of Individuals In The Country Requiring Preventive Chemotherapy For Onchocerciasis, 2013 2017
Table 91: Middle East, Reported Number Of Individuals Treated For Onchocerciasis, 2013 2017
Table 92: Middle East, Trends In Indigenous Malaria Cases, 2013 2017
Table 93: Middle East Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 94: Middle East Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Table 95: Middle East Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Table 96: Middle East Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Table 97: Middle East Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
Table 98: Israel Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 99: Saudi Arabia Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 100: Turkey Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 101: UAE Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 102: Africa, Defined Daily Doses (DDD) Per 1,000 Individuals, 2015
Table 103: Africa, Number Of Buruli Ulcer Cases, 2013 2017
Table 104: Africa, Estimated Number Of Individuals In The Country Requiring Preventive Chemotherapy For Onchocerciasis, 2013 2017
Table 105: Africa, Reported Number Of Individuals Treated For Onchocerciasis, 2013 2017
Table 106: Africa, Trends In Indigenous Malaria Cases, 2013 2017
Table 107: Africa Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 108: Africa Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Table 109: Africa Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Table 110: Africa Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Table 111: Africa Per Capita Average Anti-Infective Drugs Expenditure, By Country, 2018, $
Table 112: Egypt Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 113: Nigeria Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 114: South Africa Anti-Infective Drugs Market, 2014-2022, $ Billion
Table 115: Global Anti-infective Drugs Market, Key Competitor Estimated Market Shares, 2018, Percentage (%)
Table 116: Other Major Competitors In The Global Anti-infective Drugs Market
Table 117: Gilead Sciences Anti-infective Drugs In Pipeline
Table 118: Gilead Sciences Financial Performance, $ Billion
Table 119: Gilead Sciences Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Table 120: GlaxoSmithKline plc Anti-infective Drugs In Pipeline
Table 121: GlaxoSmithKline Financial Performance, $ Billion
Table 122: GlaxoSmithKline Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Table 123: Merck & Co Anti-infective Drugs In Pipeline
Table 124: Merck & Co. Financial Performance, $ Billion
Table 125: Merck & Co. Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Table 126: Teva Pharmaceutical Industries Ltd. Financial Performance, $ Billion
Table 127: Teva Pharmaceutical Industries Ltd. Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Table 128: Johnson & Johnson Anti-infective Drugs In Pipeline
Table 129: Johnson & Johnson Financial Performance, $ Billion
Table 130: Johnson & Johnson Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Table 131: Global Pharmaceutical Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Table 132: Global Pharmaceutical Drugs Market, 2018, Split By Region
Table 133: Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast Growth Rate, Split By Region
Table 134: Global Anti-Infective Drugs Market Size Gain ($ Billion), 2018 2022, By Country
Table 135: Global Anti-Infective Drugs Market Size Gain ($ Billion), 2018 2022, By Segment
Table 136: Global Antibiotics Market Size Gain ($ Billion), 2018 2022, By Segment
Table 137: Global Antifungals Market Size Gain ($ Billion), 2018 2022, By Segment
Table 138: Global Antivirals Market Size Gain ($ Billion), 2018 2022, By Segment
Table 139: Anti-Infective Drugs Market Data Sources
List Of Figures
Figure 1: Global Anti-infective Drugs Market Segmentation, By Product TypeFigure 2: Global Anti-Infective Drugs Industry, Supply Chain Analysis
Figure 3: Global Anti-Infective Drugs Market, PESTEL Analysis
Figure 4: Global Anti-Infective Drugs Market, Historic Market Size, 2014-2018, $ Billion
Figure 5: Global Anti-Infective Drugs Market, Forecast Market Size, 2018-2022, $ Billion
Figure 6: Global Anti-Infective Drugs Market, 2018, Split By Region
Figure 7: Global Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, Split By Region
Figure 8: Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region
Figure 9: Global Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 10: Global Antibiotics Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 11: Global Antivirals Market, Segmentation By Therapeutic Type, 2014-2022, $ Billion
Figure 12: Global Antifungals Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 13: Asia-Pacific Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 14: Asia-Pacific Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Figure 15: Asia-Pacific Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Figure 16: Asia-Pacific Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Figure 17: Australia Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 18: China Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 19: Hong Kong Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 20: India Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 21: Indonesia Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 22: Japan Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 23: Malaysia Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 24: New Zealand Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 25: Philipines Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 26: Singapore Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 27: South Korea Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 28: Thailand Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 29: Vietnam Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 30: Western Europe Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 31: Western Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Figure 32: Western Europe Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Figure 33: Western Europe Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Figure 34: Austria Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 35: Belgium Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 36: Denmark Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 37: Finland Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 38: France Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 39: Germany Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 40: Ireland Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 41: Italy Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 42: Netherlands Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 43: Norway Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 44: Portugal Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 45: Spain Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 46: Sweden Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 47: Switzerland Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 48: UK Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 49: Eastern Europe Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 50: Eastern Europe Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Figure 51: Eastern Europe Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Figure 52: Eastern Europe Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Figure 53: Czech Republic Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 54: Romania Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 55: Romania Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 56: Russia Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 57: North America Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 58: North America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Figure 59: North America Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Figure 60: North America Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Figure 61: USA Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 62: Canada Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 63: Mexico Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 64: South America Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 65: South America Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Figure 66: South America Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Figure 67: South America Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Figure 68: Argentina Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 69: Brazil Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 70: Chile Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 71: Colombia Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 72: Peru Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 73: Venezuela Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 74: Middle East Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 75: Middle East Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Figure 76: Middle East Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Figure 77: Middle East Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Figure 78: Israel Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 79: Saudi Arabia Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 80: Turkey Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 81: UAE Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 82: Africa Anti-Infective Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 83: Africa Anti-Infective Drugs Market, 2018, By Country, Value ($ Billion)
Figure 84: Africa Anti-Infective Drugs Market, 2014-2022, Historic And Forecast Growth Rate, By Country
Figure 85: Africa Anti-Infective Drugs Market, Growth And Market Share Comparison, By Country
Figure 86: Egypt Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 87: Nigeria Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 88: South Africa Anti-Infective Drugs Market, 2014-2022, $ Billion
Figure 89: Global Anti-infective Drugs Market, Key Competitor Estimated Market Shares, 2018, Percentage (%)
Figure 90: Gilead Sciences Financial Performance, $ Billion
Figure 91: Gilead Sciences Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Figure 92: GlaxoSmithKline Financial Performance, $ Billion
Figure 93: GlaxoSmithKline Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Figure 94: Merck & Co. Financial Performance, $ Billion
Figure 95: Merck & Co. Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Figure 96: Teva Pharmaceutical Industries Ltd. Financial Performance, $ Billion
Figure 97: Teva Pharmaceutical Industries Ltd. Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Figure 98: Johnson & Johnson Financial Performance, $ Billion
Figure 99: Johnson & Johnson Anti-infective Drugs Market, Estimated Revenues ($ Billion) By Geography, 2018
Figure 100: Global Pharmaceutical Drugs Market, Segmentation By Product Type, 2014-2022, $ Billion
Figure 101: Global Pharmaceutical Drugs Market, 2018, Split By Region
Figure 102: Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast Growth Rate, Split By Region
RELATED REPORTS
Anti-Infective Drugs Global Market Report 2021: COVID 19 Implications and Growth to 2030
Anti-Infective Drugs Global Market Report 2021: COVID 19 Implications And Growth to 2030 from The Business Research Company covers this critical market and the impact on it from the Covid
View ReportCOVID-19 Outbreak-Global Drug, Anti-infective Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
Drug, anti-infective: Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright.Anti-infective is a general term that encompasses antibacterials,
View ReportGlobal Anti-Infective Drugs Market Research Report 2021-2025
Anti-infective drugs are used for the purpose of killing and/or suppressing the infection causing organisms from invading the host organism by means of replication or releasing variety of toxins in
View ReportPharmaceutical Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030
Pharmaceutical Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030 from The Business Research Company provides strategists, marketers and senior management with the critical information they need
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
